Oct 13,2022

Dario's Full Suite of Digital Solutions Selected by Midwestern City to Improve Employee Health

DarioHealth Corp. announced today that a mid-sized Midwestern city selected Dario to provide its full suite of digital therapeutics solutions to several thousand city employees beginning in the first quarter of 2023. The contract is Dario's first with a government benefits entity. The City selected Dario's suite of chronic condition management solutions to support employees living with diabetes, high blood pressure, weight management needs and musculoskeletal and behavioral health needs as part of its benefits strategy to support goals around improving employee health and engagement.

PRODUCT

#dtx

#coaching

View Analyst & Ambassador Comments
Go to original news
Oct 18,2022

Medtronic leverages data science to launch first-of-its-kind personalized insights program for people living with diabetes

Medtronic is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G system. Using an individual's data, My Insights relies on the power of data science to provide personalized tips, trends, and reminders that customers can use to help with their diabetes management goals. The My Insights personalized recommendations are shared via a monthly email with educational content that is most relevant based on what an individual may currently be experiencing.

PRODUCT

#cgm

#closed loop

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 18,2022

Yes Becomes A Part of the Virgin Pulse Partner Ecosystem

Yes Health, a leading digital health provider focused on weight loss, diabetes prevention and concierge health coaching, today announced it is now part of the Virgin Pulse partner ecosystem. The program is now available to Virgin Pulse clients as part of its curated ecosystem, available via its Homebase for Health® platform addressing health, wellbeing, and navigation needs. Companies can select Yes Health from a curated collection of partners as part of the Virgin Pulse partner ecosystem, which helps employers.

COLLABORATION PARTNERSHIP

#product & service

#coaching

View Analyst & Ambassador Comments
Go to original news
Oct 19,2022

Lilly Confirms Date and Conference Call for Third-Quarter 2022 Financial Results Announcement

Eli Lilly and Company will announce its third-quarter 2022 financial results on Tuesday, Nov. 1, 2022. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance. The conference call will begin at 9 a.m. Eastern time.

View Analyst & Ambassador Comments
Go to original news
Oct 19,2022

Abbott beats The Street in Q3 on stronger medical device sales

Abbott (NYSE: ABT) today reported third-quarter results that beat the consensus forecast on Wall Street, upping its full-year EPS guidance. Investors, however, seemed to react negatively to the company’s year-over-year decline in earnings and sales in Q3. Abbott earned $1.4 billion, or 81¢ per share, off $10.4 billion in revenue for the quarter ended Sept. 30, 2022, for a bottom-line slide of nearly 32% and a top-line cut of 4.7% compared with Q3 2021.

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 24,2022

Teladoc Health Names Laizer Kornwasser as President, Enterprise Growth & Global Markets

Teladoc Health has named Laizer Kornwasser as president, enterprise growth and global markets. In this role, Kornwasser is charged with further unlocking the revenue and profit growth potential of the company’s whole person care strategy across all client channels and product lines, reporting directly to Teladoc Health CEO Jason Gorevic as a member of his executive team.

#telehealth

View Analyst & Ambassador Comments
Go to original news
Oct 24,2022

Development of automated insulin delivery systems simplifies diabetes management

Automated insulin delivery (AID) systems, or hybrid closed-loop systems, have been developed to make the job easier. Such systems allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin pump, which tracks blood glucose and automatically adjusts insulin delivery to help control blood glucose levels. According to GlobalData analysis, the CGM and insulin pumps market was valued at $10.7bn last year. It is expected to reach $20.2bn in 2030, with a compound annual growth rate (CAGR) of 7.3% from 2021 to 2030.

#insulin pump

#cgm

#closed loop

View Analyst & Ambassador Comments
Go to original news
Oct 25,2022

How Dexcom uses wearables to deliver differentiated diabetes management

Dexcom is one of the leaders in the diabetes technology space with its continuous glucose monitoring (CGM) technology. The company’s current-generation Dexcom G6 CGM remains one of the biggest players in the CGM space. Meanwhile, its next-generation Dexcom G7 CGM has already launched in a number of countries overseas. The wearable device — which features a 60% size reduction from G6 — still awaits FDA clearance.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 25,2022

Senseonics Holdings, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call

Senseonics Holdings, Inc. today announced that it plans to release its third quarter 2022 financial results after market close on Tuesday, November 8, 2022. Management will hold a conference call to review the Company’s third quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day.

CONFERENCES

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 27,2022

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care, Inc., today announced that management will present a company update at the following investor conferences: Credit Suisse 31st Annual Healthcare Conference on Tuesday, November 8, 2022 at 4:25pm ET (1:25pm PT), Jefferies London Healthcare Conference on Tuesday, November 15, 2022 at 12:20pm GMT (7:20am ET, 4:20am PT), and Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 at 4:45pm ET (1:45pm PT).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES